257 related articles for article (PubMed ID: 8171012)
21. Amplification of a SV40 T antigen transgene is associated with sarcomagenesis in mice.
Teitz T; Yen TS; Kan YW
Carcinogenesis; 1994 Sep; 15(9):2049-51. PubMed ID: 7923601
[TBL] [Abstract][Full Text] [Related]
22. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines.
Kananen K; Markkula M; Rainio E; Su JG; Hsueh AJ; Huhtaniemi IT
Mol Endocrinol; 1995 May; 9(5):616-27. PubMed ID: 7565808
[TBL] [Abstract][Full Text] [Related]
23. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene.
Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA
Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162
[TBL] [Abstract][Full Text] [Related]
24. Frequency of SV40-specific cytotoxic T-lymphocyte precursors in two SV40 T-antigen transgenic mouse lines.
Juretic A; Knowles BB
APMIS; 1991 Mar; 99(3):213-8. PubMed ID: 1850285
[TBL] [Abstract][Full Text] [Related]
25. Nucleic acid vaccination against virally induced tumors.
Bright RK; Shearer MH; Kennedy RC
Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
[TBL] [Abstract][Full Text] [Related]
26. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
[TBL] [Abstract][Full Text] [Related]
27. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen.
Schell TD; Tevethia SS
J Immunol; 2001 Dec; 167(12):6947-56. PubMed ID: 11739514
[TBL] [Abstract][Full Text] [Related]
28. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
[TBL] [Abstract][Full Text] [Related]
29. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
30. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
Zheng X; Gao JX; Zhang H; Geiger TL; Liu Y; Zheng P
J Immunol; 2002 Nov; 169(9):4761-9. PubMed ID: 12391185
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
32. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
34. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
35. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
[TBL] [Abstract][Full Text] [Related]
36. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
[TBL] [Abstract][Full Text] [Related]
37. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
[TBL] [Abstract][Full Text] [Related]
38. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen.
Soldevila G; Geiger T; Flavell RA
J Immunol; 1995 Dec; 155(12):5590-600. PubMed ID: 7499842
[TBL] [Abstract][Full Text] [Related]
39. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.
Garbi N; Arnold B; Gordon S; Hämmerling GJ; Ganss R
J Immunol; 2004 May; 172(10):5861-9. PubMed ID: 15128765
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
Bright RK; Shearer MH; Pass HI; Kennedy RC
Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
